The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
Alejandro Aruffo(University of Washington Medical Center), Mary Farrington(University of Washington Medical Center), Diane Hollenbaugh(Bristol-Myers Squibb (United States)), Xu Li(Howard Hughes Medical Institute), Athena Milatovich(Stanford University), Shigeaki Nonoyama(University of Washington Medical Center), Jürgen Bajorath(Bristol-Myers Squibb (United States)), Laura S. Grosmaire(Bristol-Myers Squibb (United States)), Ronald E. Stenkamp(University of Washington Medical Center), Michael Neubauer(Bristol-Myers Squibb (United States)), Robert L. Roberts, R J Noelle, J A Ledbetter(Bristol-Myers Squibb (United States)), Uta Francke(Stanford Medicine), Hans D. Ochs(University of Washington Medical Center)
Cited by 824
Abstract
Related Papers
No related papers found
Powered by citation graph analysis